Advanced Search

Study Preview



Study Title and Description

Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.



Key Questions Addressed
3 In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Rapamycin for treatment of chronic allograft nephropathy in renal transplant patients.
Author Stallone G., Infante B., Schena A., Battaglia M., Ditonno P., Loverre A., Gesualdo L., Schena FP., Grandaliano G.
Country Department of Biomedical Sciences, Division of Nephrology, University of Foggia, Foggia, Italy.
Year 2005
Numbers Pubmed ID: 16236802
2694 (internal)

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Comparative Effectiveness of Regimens


Results & Comparisons

No Results found.